ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
The methylase METTL3 is the writer enzyme of the N6©\methyladenosine (m6A) modification of RNA.
Here researchers report a nanomolar inhibitor of METTL3 (UZH1a) which is selective and cell©\permeable, while its enantiomer UZH1b is essentially inactive.
The authors thank Medicilon for the synthesis of the UZH1a and UZH1b compounds.
Reference:
Elena V Moroz-Omori, et al. METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes. ChemMedChem. 2021 Oct 6;16(19):3035-3043. doi: 10.1002/cmdc.202100291.